Market Research Blog

Sales of smart pill boxes and bottles are likely to reach around 800 thousand in 2019. According to a new analytical research study by Future Market Insights (FMI), smart pill boxes and bottles market will remain a high growth-low volume landscape over the course of next few years. Over 43% of total sales will be accounted by smart pill boxes. The report envisages a higher rate of adoption for smart pill bottles.

Almost 70% of adult patients are observed to discontinue or manipulate drug therapy, resulting in non-adherence to prescribed medication. The study opines that this directly adds to the economic burden on healthcare delivery system in form of emergency cases and hospitalization.

Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. Significance of medication adherence continues to rise with increasing prevalence of chronic conditions, propelling demand for smart pill boxes and bottles.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1710

Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales is accounted by aging patients and dementia-afflicted population. Cancer management is likely to emerge lucrative in terms of applicability in coming years.

With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and homecare settings are accelerating adoption of medication dispensers, thereby elevating the revenue growth of smart pill boxes and bottles market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.

Home care settings maintain the highest consumption share in smart pill boxes and bottles market that roughly equates 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at seniors care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising market opportunities for smart pill boxes and bottles manufacturers and distributors.

North America continues to reign supreme owing to early adoption of advanced technology enabled smart pill boxes and bottles, accounting for more than a third of the global market revenue. European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.

The vendor landscape of smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of share in the market in terms of volume. While dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in smart pill boxes and bottles market, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1710

Additional Questions Answered

Some of the additional questions addressed in this report on the Smart Pill Boxes & Bottles market:

• What is the overall revenue generation potential of the Smart Pill Boxes & Bottles market across the regions of Europe and South Asia?
• Who are the key regional and global competitors? What are their portfolios in the Smart Pill Boxes & Bottles market?
• What are the major challenges influencing the growth of the Smart Pill Boxes & Bottles market?

 

Future Market Insights, Dubai: As per ESOMAR-certified consulting firm Future Market Insights (FMI), the global companion animal specialty drugs market registered steady year-on-year (YoY) growth at 5.42% CAGR in 2021.

Increasing pet adoption is a major factor, fuelling the demand for animal nutrition and behavioral products, thereby accelerating sales. With increasing rate of obesity among the pet, demand for anti-obesity drugs have burgeoned over the past few years.

Adoption of canine and feline pets increased during the FQ-20, due to the outbreak of COVID-19 and consequent global shutdown. Adoption of dogs is quite high, especially among the geriatric population. This is expected to drive the demand for antibiotics, skin-care, and nutritional products for pets.

As per FMI, the market is expected to reach a valuation of US$ 36,104.66 Mn in 2021 owing to the increasing demand for anti-obesity drugs across veterinary clinics. Alongside this, prevalence of canine vector-borne diseases due to bacteria and protozoa infection will fuel the demand for parasiticides in the next decade.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3984

Key Takeaways from FMI’s Companion Animal Specialty Drugs Market Study

• By product type, parasiticides will dominate the market, accounting for over 32% of global market share.
• In terms of distribution channel, veterinary clinics are expected to lead the segment contributing over 52% of value share by 2031
• In terms of technology type, drying technology is predicted to exceed US$ 89 Bn by end 2031
• The U.S. will emerge as the leading market across North America backed by the high adoption of pet dogs
• Germany and the U.K. are anticipated to lead the Europe’s Companion animal specialty drugs market, owing to the growing obesity rate in dogs
• Increasing cases of neglect and animal cruelty in India will bolster the demand for companion animal specialty drugs through 2021

“The demand for compounded medications and anti-obesity drugs for animals will continue increasing in the coming years. This has encouraged some of the leading companies to focus on research initiatives to launch novel drugs to facilitate improved care for companion animals. This will create impressive growth opportunities in the coming years,” says the FMI analyst.

Competitive Landscape

Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. and Boehringer Ingelheim GmbH are the key players operating in the companion animal specialty drugs market. among others are some prominent players operating in the Companion animal specialty drugs market.

For instance, in July 2020, Boehringer Ingelheim announced the launch of two new products, NexGard and Broadline, to provide comprehensive parasite treatment for dogs and cats, to expand their product portfolio for the India market.

As per the report, key players are focusing on product introduction and launches to expand their product portfolios. Key player are also involved extensively in strategic acquisition activities which has led to severe competition among companion animal specialty drugs market players.

For example, on August 4,2021, Zoetis, the Parsippany-based animal health company announced the acquisition of a leading Australian-based Jurox’s veterinary medicines, maker of livestock and companion animal medicines.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-3984

What else is in the report?

Future market insights offers a unique perspective and actionable insights on companion animal specialty drugs market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021-2031 based on product type (antibiotics, anti-inflammatory drugs, parasiticides, heartworm, behavioral products, nutritional products, anti-obesity drugs, skin care products and vaccines), distribution channel (veterinary hospitals, veterinary clinics and pharmacies and drug stores) in seven key regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

 

According to a latest research by Future Market Insights (FMI), the global cell line development market size is anticipated to account for over US$ 7,200 Mn, in terms of value, by 2028 end. The report on cell line development market further projects significant growth potential with CAGR at 7.2% through 2028.

According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research. Cell lines are projected to be used for development of new treatment pathway for various disease including cancer and neurological diseases.

Click the link to get a free Sample Copy of the Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-7566

Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient treatment pathway. Companies and government organizations are investing on research and development activities and are also focusing more on cell line development in search of new cellular pathway to develop novel drugs. The increased spending on biosimilar R&D from exiting biopharmaceutical companies would provide boost to cell line development market.

In recent time the contract research organizations are focusing on cell line development and cell line research activities. According to National Institutes of Health (NIH) the estimated total federal spending on all type of stem cell line research for 2017 is US$ 1.58 Bn. In developing countries like India, government is supporting cell line development through national funding agencies like Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Department of Science and Technology (DST).

Regenerative medicines are the next generation treatment solution and Cell Line Development or Cell Culture is a vital part for regenerative medicine. Increasing demand of regenerative medicines in cancer treatment would positively impacting the growth of Cell Line Development market over the forecast period.

The biopharmaceutical companies operating in development of novel drug line are expected to hold promising revenue opportunity in cell line development market.

Future Market Insights (FMI) has segmented the cell line development market based on product type, cell line source type, end user, type of cell line and region.

Product type segment in cell line development market is segmented into media and reagents, equipment and accessories. Reagents and Media are required from incubation to preservation of cell lines. These products are expensive and have repetitive use in cell culture or bio-production. Reagent and media segment in cell line development market is expected witness noteworthy growth in terms of revenue owing to rapid increase in demand in cell culture and cell based assays.

Cell line development market by cell line source is categorized into mammalian cells and non-mammalian cells. Mammalian cell line development is anticipate to witness significant growth in overall cell line development market. This growth of mammalian cells segment in cell line development market is driven by increased production of biologics drugs which require mammalian cells. Increasing antibody production is the major driving factor behind the growth of mammalian cell lines segment in cell line development market.

Mammalian cell lines are used to create therapeutic proteins through genetic building and antibodies through viral infection. For example, Gaucher’s disease, which is a genetic disorder characterized by lack of β-glucocerebrosidase enzyme and can be treated by Cerezyme which is a recombinant enzyme produces in mammalian cell lines. Mammalian cell lines are also useful in production of antibodies and other therapeutic agents such as specific binding proteins that can neutralize disease causing agents in the body. For example Under cell line type segment in cell line development market, recombinant cell line development are the most demanding type of cell line due to large application in biologics production, protein interaction, gene activation, toxicity testing and drug screening.

Ask More Questions About Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-7566

Growing application recombinant cell line development in drug toxicity testing is expected to boost the growth of overall cell line development during the forecast period

North America and Europe cell line development market will dominate in owing to increasing government funding in cell line development research and rising spending on biosimilar developments. Asia Pacific cell line development market is expected to grow at a high growth rate due to increased number of research organization engaged in novel biologics and biosimilar fastest revenue growth in overall cell line development market.

The Asia Pacific region in Cell line development market is anticipate to witness increasing demand of biopharmaceuticals and regenerative medicines are expected to boost the growth of the cell line development market.

FMI’s report tracks some of the key companies operating in the cell line development market, such as Selexis SA, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., American Type Culture Collection (ATCC), Lonza (Sartorius Stedim Biotech S.A.), Danaher Corporation, Merck KGaA, WuXi Biologics.

 

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.

Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.

Click the link to get a free Sample Copy of the Report @ Click the link to get a free Sample Copy of the Report @

 

Key Takeaways – Lacrimal Duct Stent Tube Market Study

• Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
• Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
• Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
• Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.

Ask More Questions About Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-9649

Know More About Lacrimal Duct Stent Tube Market Report

Future Market Insights brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global lacrimal duct stent tube market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on lacrimal duct stent tube market on basis of product type (monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers), across seven major regions.

 

Urinary tract infection is one of the most common bacterial infection affecting almost 150 million people worldwide. Urinary tract infection mostly occurs in urinary tract which is caused by bacteria, viruses and fungi. Some of the bacteria that cause urinary tract infection such as Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, Proteus species and Enterococcus species. According to Center for Disease Control and Prevention urinary tract infection surveillance report 2018, an estimate of 93,300 morbidity cases were observed in acute care hospitals. Recurrent urinary tract infection is a major health issue in females across the globe. According to European Association of Urology, there is an increase in bacterial resistance to antibiotics in the region which leads to more research and development for novel therapeutics. With latest upcoming techniques, urinary tract infection testing market will fuel the growth of the market

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10134

Urinary Tract Infection Testing: Market Dynamics

Urinary tract infection is expected to register significant growth in the market owing to rising prevalence of urinary tract infection globally. Increasing geriatric population is a another factor that is expected to boost the demand for urinary tract infection testing as the elderly population is at the high risk of contracting the same. Moreover, patients that use urinary catheters are more likely to contract complicated urinary tract infection. This adds on another factor that will spur the growth of the urinary tract infection testing market. Apart from this, manufacturers are currently focus on developing new imaging techniques for urinary tract infection testing which may drive the growth of the urinary tract infection testing market. However, stringent and complex regulatory approvals for new launch of equipment and lack of government funding for research and development in developing countries may restrain the growth of the market.

Urinary Tract Infection Testing Market: Overview

There has been an increase in the number of urinary tract infection patients across the globe. Urinary tract infection contributes to the second-largest patient pool in the world. Increasing prevalence and demand for better treatment option is likely to foster the growth of the market. Launch of new testing kits and devices will accelerate the growth of the urinary infection testing market. For instance, in June 2019, MiDOG, LLC announced the launch of new collection of urine kit and test for the diagnosis of fungal and bacterial pathogens in urinary tract infections of canine. With the launch of new technologies and increase in number of urinary tract infection testing kits and devices players, the urinary tract infection testing will spur the growth of the market.

Urinary Tract Infection Testing: Region-wise Outlook

On the basis of geography, the global urinary tract infection testing market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding Japan and Middle East & Africa. North America is expected to anticipate substantial revenue generation in urinary tract infection testing market owing to advancement in research and development, increased in launch of new urinary tract infection testing devices and instruments. Europe also share significant revenue generation in urinary tract infection testing market owing to increase in adoption of new technologies and improved healthcare infrastructure. Asia Pacific has significant potential in stimulating the growth of the urinary tract infection testing market due to increasing prevalence of urinary tract infection and rising awareness about various bacterial infection. Middle East and Africa has less impact in urinary tract infection testing market due to poor healthcare infrastructure and less availability of diagnostic procedures which may hinder the growth of the urinary tract infection testing market.

Urinary Tract Infection Testing Market: Key Players

Some of the key players present across the value chain of the global urinary tract infection testing market are Laboratory Corporation of America Holdings, Stryker, PENTAX Medical, Seimens Healthineers, Sysmex Corporation, Cardinal Health, Roche Diagnostics, Arkray Inc, Alere Inc., Streck, Quidel Corporation, Beckman Coulter, Bio-Rad Laboratories, DIRUI, ACON Laboratories, URIT Medical Electronic Ltd.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Urinary Tract Infection Testing Market: Segmentation

The global urinary tract infection testing market is segmented by test types and end user

Urinary Tract Infection Segmentation by Test

• Laboratory Test
• Urinalysis urinary tract infection testing
• Urine culture urinary tract infection testing
• Susceptibility urinary tract infection testing
• Non-laboratory Test
• Kidney and bladder ultrasound urinary tract infection testing
• Nuclear scans urinary tract infection testing
• Cystoscopy urinary tract infection testing
• Voiding cystourethrogram (VCUG) urinary tract infection testing

Urinary Tract Infection Segmentation by End User

• Hospitals
• Diagnostics Laboratories
• Research Institutes
• Others

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-10134

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance

 

At-Home Vaginal pH Test kits are used to measure the pH of the vaginal secretion. At-Home Vaginal pH Test is a qualitative test to find out the unbalanced pH level of the vaginal secretion. At-Home Vaginal pH Test is performed in case of unusual vaginal symptoms such as unpleasant odor, burning, itching or unusual discharge.

At-Home Vaginal pH Test is useful to decide whether the patient suffering from unusual vaginal symptoms. However, the at-home vaginal pH test will not help for the diagnosis of group B streptococcus HIV, gonorrhea, herpes, syphilis, or chlamydia.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8318

At-Home Vaginal pH Test Kit: Drivers and Restraints

At-Home Vaginal pH Test allows the early detection of vaginal infections. A normal vaginal pH is between 3.8 and 4.5. If the vaginal pH is detected using at-home vaginal pH test kits is 5.0 or more indicates the presence of either trichomoniasis or bacterial vaginosis. On the other hand, the lower pH than 3.5 indicates the presence of yeast infection. Moreover, the at-home vaginal pH test kits are a cost-effective option for the early detection of vaginitis at home without visiting the physician. Moreover, the at-home vaginal pH test kit is also useful to maintain the pH balance of vaginal area, early diagnosis of the disorder related to vaginal flora, to prevent the vaginal infection, the at-home vaginal pH test kit is also useful for greater safety during pregnancy, to monitor the effectiveness of any treatment. These factors and advantages are expected to propel the market of at-home vaginal pH test kits.

However, the results of at-home vaginal pH test kits may not be accurate if the woman has recently had intercourse or if the women are on her period. In most of the cases, the patient should still see a physician or gynecologists to get the most correct diagnosis even after using at-home vaginal pH test. These factors are expected to negatively impact the growth of the at-home vaginal pH test kits market.

At-Home Vaginal pH Test Kit Market: Overview

Global At-Home Vaginal pH Test Kit Market has witnessed growth due to rising awareness feminine hygiene and rising incidence of vaginitis.

At-Home Vaginal pH Test Kit Market: Region-wise Outlook

Geography wise, At-Home Vaginal pH Test Kit Market is divided into eight regions such as North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. North America’s At-Home Vaginal pH Test Kit Market is expanding because of high adoption rate and it will remain dominant over the period of forecast due to rising incidence of vaginitis and rising awareness for feminine hygiene.

At-Home Vaginal pH Test Kit Market: Key Market Participants

Some of the market participants in the Global At-Home Vaginal pH Test kit market identified across the value chain include: Hometest, Bayer AG, Prestige Consumer Healthcare, Inc., GRÜNSPECHT Naturprodukte GmbH, Vagisil, Dream Future Innovation.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

At-Home Vaginal pH Test Kit Market: Segmentation

To gain a comprehensive and better understanding of the future market equity, the market report is segmented based on the distribution channel and region.

On the basis of distribution channel, At-Home Vaginal pH Test Kit Market can be segmented as:

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy
• Fertilization Centers

On the basis of geography, At-Home Vaginal pH Test Kit Market can be segmented as:

• North- America
• Eastern Europe
• Western Europe
• Asia-Pacific excluding China & Japan
• China
• Japan
• Middle East and Africa
• Latin America

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-8318

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint